Kallikrein-related peptidases (KLKs) are a family of 15 secreted serine proteases with chymotrypsin-and trypsin-like activities.
| EXPERIMENTAL DESIGN
See e-supporting information.
| RESULTS
To investigate the role of Klk6 in the development of psoriasiform dermatitis, we first examined the expression and localization of Klk6.
Immunofluorescence analysis showed that, while no Klk6 protein expression was detected in the upper epidermis of untreated skin, its expression was markedly increased in IMQ-treated skin ( Figure 1A ).
Klk6 protein was located in both cytoplasm and intercellular spaces,
suggesting that it is secreted from keratinocytes. Furthermore, quantitative RT-PCR analysis confirmed that the expression of Klk6 mRNA was elevated in IMQ-treated skin ( Figure S1A , S1B). To further assess the role of Klk6, we examined the development of psoriasiform dermatitis in Klk6 knockout mice. IMQ-treated skin of wild-type mice showed characteristic acanthosis and hyperkeratosis. Conversely, these changes were significantly less evident in Klk6 knockout mice ( Figure 1B-D) . Histological analysis also revealed that the number of neutrophils was markedly lower in IMQ-treated skin of Klk6 knockout mice ( Figure 1E , S1C), suggesting that Klk6 promotes neutrophil infiltration into skin in this model. Furthermore, IMQ-induced ear swelling was reduced after deleting Klk6 ( Figure S2A ). Quantitative RT-PCR showed that the IMQ-induced expression of psoriasis-associated cytokines (IL-17A, IL-17F, IL-22, CXCL2 and CXCL3) or other epidermal Klks (Klk5, Klk7, Klk8 and Klk14) was also markedly reduced in the skin of Klk6 knockout mice ( Figure S2B, S4) . Taken together, our data indicate that Klk6 is required for the development of psoriasiform skin inflammation by promoting neutrophil infiltration.
Previous reports showed that KLK6 contributes to activation of PAR2 by proteolytic cleavage (2, S2). As PAR2 activation in keratinocytes is the important effector of skin inflammation (3, S3), we hypothesized that Klk6 promotes IMQ-induced dermatitis by activating PAR2. Immunofluorescence analysis revealed that IMQ treatment increased PAR2 staining, which was located in cytoplasm of the upper epidermal keratinocytes (Figure 2A ). This subcellular localization is Abbreviations: IMQ, imiquimod; KLK, human kallikrein-related peptidase; Klk, mouse kallikrein-related peptidase; PAR, protease-activated receptor.
consistent with the internalization of PAR2 following its activation.
To further investigate the role of PAR2 activation, we examined the development of psoriasiform dermatitis in PAR2 knockout mice.
Unexpectedly, PAR2 knockout mice developed skin lesions similar to those in wild-type mice, including acanthosis and hyperkeratosis ( Figure 2B-D) . Furthermore, IMQ-induced ear swelling was not affected after deleting PAR2 ( Figure S3 ), suggesting that PAR2 signalling is dispensable in this model. Collectively, these data suggest that Klk6 promotes psoriasiform skin inflammation in a PAR2-independent manner.
| CONCLUSION
In this study, we demonstrated that Klk6 expression was strongly induced in IMQ-treated psoriasiform epidermis. Furthermore, we showed that Klk6 is crucial for the development of IMQ-induced psoriasiform dermatitis, suggesting that it may play a role in the pathology of human psoriasis. Our data also suggest that Klk6 promotes psoriasiform skin inflammation in a PAR2-independent manner.
Genomewide transcription profiling showed that various KLKs, including KLK6, are highly expressed in psoriatic skin.
[8] Indeed, multiple KLK proteins are detectable at higher levels in the epidermis and serum of patients with psoriasis. [5] Although the mechanism of KLK induction in psoriasis is poorly understood, a previous study showed that IL-17, a pivotal cytokine in psoriasis, stimulates KLK6 expression in reconstituted human epidermis. [9] This observation suggests that IL-17 may induce KLK6 expression in both human psoriasis and mouse IMQ model.
Although our data demonstrate that Klk6 promotes skin inflammatory response in mice, the precise mechanism is unclear. Unexpectedly, our data indicated that PAR2 is dispensable for the development of psoriasiform skin inflammation. There are several possible ways in which Klk6 affects IMQ-induced dermatitis. For example, KLK6 may act through PAR1, which is another PAR member involved in inflammatory signalling in keratinocytes. [4] Another possibility is that KLK6 may modulate tissue remodelling and cell migration by degrading components of the extracellular matrix such as fibrinogen and various collagens. Thus, further studies are required to identify the Klk6 substrate and determine the mechanism by which Klk6 promotes skin inflammation.
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